Document is current
Any future updates will be listed below
-
Authors
Zhang, Shaowei
Sakuma, Michiyo
Deora, Girdhar S. https://orcid.org/0000-0001-9857-101X
Levy, Colin W.
Klausing, Alex https://orcid.org/0000-0001-6863-7786
Breda, Carlo
Read, Kevin D.
Edlin, Chris D.
Ross, Benjamin P. https://orcid.org/0000-0002-1899-8484
Wright Muelas, Marina
Day, Philip J.
O’Hagan, Stephen
Kell, Douglas B. https://orcid.org/0000-0001-5838-7963
Schwarcz, Robert
Leys, David
Heyes, Derren J. https://orcid.org/0000-0002-7453-1571
Giorgini, Flaviano
Scrutton, Nigel S.
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/P009042/1; BB/R000093/1 and BB/M017702/1)
RCUK | Engineering and Physical Sciences Research Council (EP/J020192/1)
RCUK | Medical Research Council (MR/N00373X/1)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (P50 MH103222)
Leicester Drug Discovery and Diagnostics (LD3) University of Leicester
- License Information
-
More Information
Article History
Received: 30 July 2018
Accepted: 28 June 2019
First Online: 24 July 2019
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: a patent (new compounds and uses) from the University of Leicester and University of Manchester by N.S.S. and F.G. is pending, application number 1719327.7.
